Clinical Trial Update: 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing 5% KOH solution to placebo and diclofenac gel for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• 5% KOH solution
• Diclofenac Gel (diclofenac)

Snippet

Sponsor: Infectopharm Arzneimittel GmbH | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED